Change of Management in Evonik’s Health & Nutrition Business Unit
Dr. Hans-Josef Ritzert, head of Evonik Industries AG’s catalysts Business Line, will take over management of the Exclusive Synthesis & amino acids Business Line effective April 1, 2009. His predecessor, Dr. Rudolf Hanko, will leave the company on May 1, 2009, to assume the position of CEO at Siegfried Holding, Zofingen, Switzerland, immediately.
To become acquainted with his new function, Dr. Ritzert will hand over management of the Catalysts Business Line to Dr. Wilfried Eul as early as April 1. Eul was responsible for managing Rexim´s business for Pharmaceutical Amino Acids and headed the Asia Region for Exclusive Synthesis & Amino Acids.
Until further notice, Dr. Ritzert will perform Dr. Eul’s job as head of Rexim and regional president.
Most read news
Other news from the department people

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.